Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00087386
What this trial is testing

Tanespimycin in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage III MelanomaStage IV Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00254579
What this trial is testing

Study of CP-675,206 in Refractory Melanoma

Who this might be right for
Refractory Melanoma
AstraZeneca 251
Not applicableEnded earlyNCT04473027
What this trial is testing

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs

Who this might be right for
MelanomaCancer
University Hospital, Ghent 3
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Very early researchStudy completedNCT01568996
What this trial is testing

Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions

Who this might be right for
Atypical NeviMelanoma
John Kirkwood 17
Not applicableStudy completedNCT04920162
What this trial is testing

Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

Who this might be right for
Melanoma and Vitiligo
Centre Hospitalier Universitaire de Nice 10
Testing effectiveness (Phase 2)Ended earlyNCT02740920
What this trial is testing

Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker

Who this might be right for
Metastatic Melanoma
Canadian Cancer Trials Group 9
Testing effectiveness (Phase 2)Looking for participantsNCT07281924
What this trial is testing

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Who this might be right for
Metastatic MelanomaLiver Metastases
University of Wisconsin, Madison 15
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Not applicableStudy completedNCT00597961
What this trial is testing

Health Communication in Families

Who this might be right for
Lung CancerMelanomaSkin Cancer
Memorial Sloan Kettering Cancer Center 42
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Testing effectiveness (Phase 2)UnknownNCT02023710
What this trial is testing

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 182
Early research (Phase 1)Study completedNCT00970996
What this trial is testing

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT05457842
What this trial is testing

Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery

Who this might be right for
Sentinel Lymph Node BiopsyBreast CancerMelanoma
Astellas Pharma Inc 1
Early research (Phase 1)UnknownNCT03385486
What this trial is testing

Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

Who this might be right for
Stage III MelanomaStage IV Melanoma
Taiga Biotechnologies, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00188370
What this trial is testing

Ultrasound Biomicroscopy - Apoptosis

Who this might be right for
LymphomaLymphoma, Non-HodgkinMelanoma+1 more
University Health Network, Toronto 50
Testing effectiveness (Phase 2)UnknownNCT03808441
What this trial is testing

CAcTUS - Circulating Tumour DNA Guided Switch

Who this might be right for
Melanoma
The Christie NHS Foundation Trust 21
Testing effectiveness (Phase 2)UnknownNCT02968303
What this trial is testing

Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy

Who this might be right for
Melanoma, Malignant, of Soft Parts
Radboud University Medical Center 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05732805
What this trial is testing

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

Who this might be right for
MelanomaMelanoma (Skin)Melanoma Stage III+4 more
Biocad 270
Not applicableUnknownNCT05075356
What this trial is testing

IToBoS: Clinical Data Acquisition Study

Who this might be right for
Melanoma
The University of Queensland 600
Next Page